From: Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer
Characteristic | EORTC QLQ-C30 | FACT-G |
---|---|---|
N = 903 | N = 908 | |
Age (years) | 68 (58–74) | 68 (58–74) |
Sex | ||
 Male | 489 (54.2) | 489 (53.9) |
 Female | 414 (45.8) | 419 (46.1) |
Hospitalization | ||
 Yes | 186 (20.6) | 180 (20.8) |
 No | 717 (79.4) | 719 (79.2) |
ECOG performance status | ||
 0 | 451 (49.9) | 447 (49.2) |
 1 | 368 (40.8) | 377 (41.5) |
 2 | 63 (7.0) | 64 (7.0) |
 3 | 20 (2.2) | 19 (2.1) |
 Unknown (0, 1, 2, or 3) | 1 (0.1) | 1 (0.1) |
Tumor type | ||
 Lung cancer | 317 (35.1) | 312 (34.4) |
 Stomach cancer | 65 (7.2) | 64 (7.0) |
 Colorectal cancer | 222 (24.6) | 226 (24.9) |
 Breast cancer | 113 (12.5) | 116 (12.8) |
 Other solid tumors | 186 (20.6) | 190 (20.9) |
Stage at diagnosis | ||
 I | 49 (5.4) | 48 (5.3) |
 II | 70 (7.8) | 70 (7.7) |
 III | 184 (20.4) | 185 (20.4) |
 IV | 588 (65.1) | 593 (65.3) |
 Unknown | 12 (1.3) | 12 (1.3) |
Site of metastasis or recurrencea | ||
 None | 77 (8.5) | 81 (8.9) |
 Liver | 198 (21.9) | 204 (22.5) |
 Lung | 285 (31.6) | 280 (30.8) |
 Bone | 160 (17.7) | 165 (18.2) |
 Brain | 98 (10.9) | 98 (10.8) |
 Lymph nodes | 361 (40.0) | 361 (39.8) |
 Others | 225 (24.9) | 227 (25.0) |
History of surgery | ||
 Yes | 480 (53.2) | 483 (53.2) |
 No | 422 (46.7) | 424 (46.7) |
 Unknown | 1 (0.1) | 1 (0.1) |
Type of treatmenta | ||
 Chemotherapy | 582 (64.5) | 590 (65.0) |
 Endocrine therapy | 65 (7.2) | 66 (7.3) |
 Molecular targeted therapy | 159 (17.6) | 158 (17.4) |
 Immunotherapy | 108 (12.0) | 104 (11.5) |
 Palliative therapy | 35 (3.9) | 37 (4.1) |
 Others | 8 (0.9) | 8 (0.9) |